Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd (formerly Sun Techno Overseas Ltd) held its 30th AGM on 25th September 2025 via video conferencing. All six resolutions were passed with near-unanimous approval, with 100% of polled votes in favor on every item. About 27.75% of the 90.26 crore outstanding shares were voted (roughly 25.05 crore shares), with 35 public shareholders participating and no promoter shareholders present. The resolutions covered adoption of FY25 audited financial statements, re-appointment of the Statutory Auditor, appointment of Mr. Kelash Bunkar as Wholetime Director and CFO, appointment of Mr. Aman Patel as Independent Director, enhancement of borrowing limits under Section 180(1)(c), and expanded powers to give loans, guarantees, and investments under Section 186.
Routine procedural outcome with no dissent — the new WTD/CFO and Independent Director are now formally appointed, and the company has secured shareholder approval to raise borrowings and make investments beyond existing statutory caps, giving it more financial flexibility. The very low voting turnout (under 28% of shares) and the lack of any promoter shareholding point to a widely-held, thinly-traded stock, so these approvals carry limited new information for existing shareholders.